Ignite Creation Date:
2024-05-06 @ 7:34 PM
Last Modification Date:
2024-10-26 @ 3:09 PM
Study NCT ID:
NCT06064552
Status:
RECRUITING
Last Update Posted:
2023-10-03
First Post:
2023-09-26
Brief Title:
Screening For First Trimesters Hyperglycemia in High and Low Risk Pregnancy
Sponsor:
Sohag University
Organization:
Sohag University
Study Overview
Official Title:
Screening For First Trimesters Hyperglycemia in High and Low Risk Pregnancy
Status:
RECRUITING
Status Verified Date:
2023-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Glucose intolerance is the commonest medical disorder complicating pregnancy Hyperglycemia increases the risk of delivering a large for gestational age newborn LGA and related complications such as operative delivery birth trauma and the poor adaptation of the newborn Maternal risks of GDM include also polyhydramnios preeclampsia premature delivery prolonged labor uterine atony postpartum hemorrhage infection and progression of retinopathy which are the leading global causes of maternal morbidity and mortality Detection of women at higher risk for GDM early in pregnancy is a desirable goal because interventions such as diet medication and exercise may be applied earlier in pregnancy and potentially can reduce later development of GDM or its associated morbidities Most GDM cases are diagnosed after mid-gestation following an abnormal glucose challenge test GCT However about 10 of patients with GDM can be diagnosed in the first trimester
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None